Suven Life Sciences Limited

Ramkumar Subramanian

Venkateswarlu Jasti

Ramakrishna Nirogi

Anil Karbhari Shinde

Abdul Rasheed Mohammed

Pradeep Jayarajan

Vijay Sidram Benade

Gopinadh Bhyrapuneni

Narsimha Bogaraju

Jyothsna Ravula

Rajesh Kumar Badange

Vinod Kumar Goyal

Srinivasa Rao Ravella

Santosh Kumar Pandey

Kumar Bojja

Sangram Keshari Saraf

Abdul Rashee Mohammed

Satish Jetta

Raghava Chowdary Palacharla

The present invention relates to heteroalicyclic compounds represented by the general formula (I), or their isotopic forms, stereoisomers, or pharmaceutically acceptable salts thereof. The present invention also describes a method of making such compounds, pharmaceutical compositions comprising such compounds and their use for the treatment or prevention of central nervous system related disorders.

Substituted piperidines and piperazines and methods for the treatment of CNS disorders

The present invention relates to substituted heterocyclic compounds represented by the general formula (I), or their isotopic forms, stereoisomers, or pharmaceutically acceptable salts thereof. The present invention also describes the method of making such compounds, pharmaceutical compositions comprising such compounds and their use in the treatment of central nervous system disorders.

Benzoisothiazole and benzoisoxazole compounds for the treatment of mental disorders

The present invention relates to compounds of formula (I), or their isotopic forms, stereoisomers, tautomers or pharmaceutically acceptable salt(s) thereof as muscarinic M1 receptor positive allosteric modulators (M1 PAMs). The present invention describes the preparation, pharmaceutical composition and the use of such compounds. (I)

Pyrrolo-pyridazine derivatives as muscarinic M1 receptor positive allosteric modulators

The present invention relates to compound of formula (I), or stereoisomers and pharmaceutically acceptable salts as muscarinic M1 receptor positive allosteric modulators. This invention also relates to methods of making such compounds and pharmaceutical compositions comprising such compounds. The compounds of this invention are useful in the treatment of various disorders that are related to muscarinic M1 receptor. (Formula I)(I) 

Fluoroindole derivatives as muscarinic M1 receptor positive allosteric modulators

The present invention relates to compounds of formula (I), including their stereoisomers and pharmaceutically acceptable salts. This invention also relates to methods of making such compounds and pharmaceutical compositions comprising such compounds. The compounds of this invention are useful in the treatment of various disorders that are related to 5-hydroxytryptamine 4 (5-HT) receptor.

Amide compounds as 5-HT4 receptor agonists

Growing community of inventors

Telangana, India

Ramkumar Subramanian